Ummati Islamic Website
Related Articles
January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a ‘Public Health Emergency of International Concern’
March 2020: Then Prime Minister Boris announced the first national lockdown. That same month, the Government invests £88million in the development of the Oxford vaccine
April 2020: Alongside AstraZeneca, scientists start the first clinical trials of their new vaccine. This involved 1,000 volunteers in the UK
July 2020: Results from phase two trials of AstraZeneca’s jab are published
4 December 2020: Covid jab rollout begins with the Pfizer vaccine. Over-80s and care home workers are given priority
8 December 2020: Phase three trial results of the AstraZeneca’s jab are published. These are what health officials will use to approve the jab for use in the UK
30 December 2020: AstraZeneca’s jab is approved for emergency use
4 January 2021: First AstraZeneca doses start being dished out. Brian Pinker, 82, is the first person to receive the jab outside of clinical trials
8 January 2021: Frontline NHS staff start being offered vaccines
8 February 2021: Over-70s are called forward
14 February 2021: Roll-out opens up to Brits with underlying heath conditions, as well as the over-65s
28 February 2021: All over-60s are invited for jabs
11 March 2021: European countries start suspending use of the AstraZeneca jab after death of a 60-year-old woman from a blood clot
17 March 2021: Over 50s start being offered Covid jabs in the UK
19 March 2021: Several European countries reverse decision to suspend AstraZeneca jab after initial investigations find no link to reported blood clots
31 March 2021: People living with vulnerable adults are called forward to get a Covid vaccine in the UK, even if they are younger than eligible age groups
7 April 2021: UK restricts the use of the AstraZeneca vaccine to over-30s over a small but statistically significant risk of blood clots in younger people
30 April 2021: Over-40s are called forward for Covid jabs
7 May 2021: Restriction of the AstraZeneca vaccine is widened to include over-40s
August 2022: Government sources say they will not order anymore AstraZeneca Covid vaccines instead focuses on mRNA alternatives
March 2023: Dozens of patients and families launch legal action against AstraZeneca due to
April 2023: Widower of a BBC presenter Lisa Shaw who died after having the vaccine said he has ‘no alternative’ but to sue AstraZeneca
4 August 2023: Anish Tailor, whose wife Alpa died in March 2021 after receiving her first AstraZeneca dose, filed a product liability claim against AstraZeneca at London’s High Court. His lawyer says he has nearly 50 other clients who will formally sue AstraZeneca in the coming months
17 August 2023: IT engineer Jamie Scott, who suffered a brain haemorrhage the day after his first AstraZeneca jab starts a legal case against the company. The law firm representing Mr Scott says it represents around 40 other individuals or bereaved families.
30 April 2024: Pharmaceutical giant AstraZeneca has for the first time admitted that its Covid-19 vaccine could cause a rare side effect that can lead to blood clots and death, according to court documents.
The company is fighting a class action lawsuit alleging that its inoculation, which was developed in collaboration with the University of Oxford, can result in death and serious injury.
According to the Independent:
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
Pharmaceutical giant AstraZeneca has admitted that its widely used Covid vaccine, branded Covishield, can cause rare side effects including blood clots and low platelet count.
Covishield was developed by the British-Swedish company in collaboration with Oxford University, UK, and produced by the Serum Institute of India. It was widely administered in over 150 countries, including Britain and India
One of the complainants alleged that the vaccine caused him a permanent brain injury after he developed a blood clot, preventing him from working.
While AstraZeneca has contested these claims, it admitted for the first time in one of the court documents that the vaccine can “in very rare cases, cause TTS”, or Thrombosis with Thrombocytopenia Syndrome, which is characterised by blood clots and a low blood platelet count in humans.
“It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known,” the company said in the court documents in February, The Telegraph reported.
“Further, TTS can also occur in the absence of the AZ vaccine (or any vaccine). Causation in any individual case will be a matter for expert evidence,” it added.
The admission by AstraZeneca runs counter to the company’s insistence in 2023 that it would “not accept that TTS is caused by the vaccine at a generic level”.
The World Health Organization confirmed that Covishield can have life-threatening side effects. “A very rare adverse event called Thrombosis with Thrombocytopenia Syndrome, involving unusual and severe blood clotting events associated with low platelet counts, has been reported after vaccination with this vaccine.”
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots (yahoo.com)
